Novo Nordisk

News

Novo's diabetes pill beats injections in head-to-head trials

Novo Nordisk is making the case for its diabetes pill, which it hopes will allow it to fight off competition from rivals in a highly competitive market.

Views & Analysis

Top pharmaceutical companies in the world in 2017

The rankings of the top pharmaceutical companies in the world in 2017 presented a mixed picture, with stability for some of the 25 largest firms as others saw their value fall.

News

Novo expands type 1 diabetes R&D

Company will also focus on serious chronic diseases

News

Novo Nordisk ties discounts to adherence in SMS pilot

Novo Nordisk is working with a digital health start-up to link better medication adherence to lower medicine costs for diabetes patients in the US through a text messaging pilot.

News

Novo cleared to add key data to Tresiba label

Novo Nordisk can add data showing Tresiba can reduce the risk of hypoglycaemia to its label, a development which should help its fight competition from cheaper alternati

News

Trulicity helps SGLT-2 patients lower blood sugar

New phase 3b trial results show Lilly’s Trulicity combined with an SGLT2 inhibitor failed to show any benefits above and beyond Trulicity’s blood glucose lowering.

Novo's diabetes pill beats injections in head-to-head trials

Top pharmaceutical companies in the world in 2017

Novo expands type 1 diabetes R&D

Novo Nordisk ties discounts to adherence in SMS pilot

Novo cleared to add key data to Tresiba label

Trulicity helps SGLT-2 patients lower blood sugar

CEPI steps in to fund Moderna's pandemic flu jab

How to meet your physicians where they are online

Novo Nordisk

Editor's Picks